Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa.
Subject: Anorexia - PUBLISHED VIA Journal of Psychiatric Research
Author(s):
Støving RK, Andries A, Brixen K, Flyvbjerg A, Hørder K, Frystyk J
View Source >>
(Price: $36)
Related Studies:
The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence.
Published via Current Pharmaceutical Design
Cancer cachexia and cannabinoids.
Published via Forsch Komplementarmed